Objective: Vitamin D deficiency may play a role in the pathogenesis of preeclampsia by causing abnormal placental implantation and by affecting the inflammatory response. The aim of this study was to compare the cord blood vitamin D level in neonates born to preeclamptic mothers with that of a control group of newborns whose mothers were not preeclamptic.
INTRODUCTION
Preeclampsia is a pregnancy-specific disease characterized by hypertension and proteinuria that typically begins after the 20 th gestational week. [1] Preeclampsia occurs in 5% to 8% of all pregnancies and is considered one of the leading causes of fetal growth retardation, neonatal morbidity and mortality, premature birth, and maternal death. [2, 3] Primipara pregnancy, twin pregnancy, history of preeclampsia in a previous pregnancy, chronic hypertension, and obesity are important risk factors. [4] Although the etiology and pathogenesis are not fully understood, it is believed that maternal endothelial cell dysfunction and placental malformation play a key role in preeclampsia. [5] In recent years, it has been shown that vitamin D has an effect on endothelial function and adaptive and natural immunosystems, as well as its known effects on calcium and phosphorus metabolism. [6] Vitamin D also plays a role in the expression of genes that affect implantation of an embryo. [7] It is thought that vitamin D deficiency may cause abnormal placental implantation and increase the risk of preeclampsia by influencing the inflammatory response and immune functions. [8, 9] Several studies have examined a linear relationship between vitamin D deficiency and preeclampsia. [10, 11] In some epidemiological studies, an association between preeclampsia and a low vitamin D level during pregnancy has suggested that vitamin D may be an independent risk factor in the pathogenesis of preeclampsia. [12] [13] [14] [15] [16] However, the precise mechanisms of an association between vitamin D level and preeclampsia have not yet been established.
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Studies have shown a strong correlation between the blood vitamin D level in a mother and the level found in the umbilical cord. While fetal calcium levels are higher than maternal calcium levels during pregnancy, the concentration of vitamin D in umbilical cord blood and maternal vitamin D levels are similar. [16] [17] [18] [19] [20] Although many studies have been conducted examining the relationship between maternal preeclampsia and vitamin D level, a limited number of studies have evaluated the vitamin D level in the cord blood of preeclamptic mothers.
The aim of this study was to evaluate the hypothesis that a low vitamin D level and preeclampsia have a linear correlation. A control group of healthy pregnant women was used as a control group for a comparison of the cord blood vitamin D level.
MATERIALS AND METHODS
The study group consisted of mothers diagnosed with moderate and severe preeclampsia according to the guidelines of the American College of Obstetricians and Gynecologists and their newborns. The control group comprised non-preeclamptic mothers with newborns of similar gestational age and birth weight to the study group. Mothers diagnosed with chronic hypertension before pregnancy, and those with newborns diagnosed with congenital heart disease were not included in the study. Ethics committee approval was obtained for the research. The participating families were informed about the study parameters and they provided written consent.
Collection of blood samples
Blood samples (1.5 mL) were drawn from the umbilical cord into gel tubes. The samples were centrifuged at 5000 rpm at +4°C for 5 minutes. The serum was separated and stored at -30°C until the day of the study.
The magnesium content measured in serum samples obtained from the mothers just before birth was recorded for comparison.
Samples drawn to examine the serum vitamin D levels (25-hydroxy vitamin D) were studied using a Liaison analyzer and a DiaSorin kit (DiaSorin S.p.A., Saluggia, Italy) applying the chemiluminescent immunoassay method.
Statistical analysis
NCSS 2007 and PASS 2008 statistical software (NCSS, LLC, Kaysville, UT, USA USA) were used to perform the statistical analysis. Descriptive statistical methods (mean, SD, median, frequency, ratio, minimum, maximum) were used for intergroup comparisons of quantitative data with normal distribution determined using Student's t-test, and comparisons of parameters with non-normal distribution were performed with the Mann-Whitney U test. One-way analysis of variance testing was used in the comparison of 3 or more groups with normal distribution and Tukey's honest significant difference test was employed to identify an intergroup difference.
The Kruskal-Wallis test was used for the comparison of 3 or more groups without normal distribution and the Mann-Whitney U test was used to identify a significantly different group. Pearson's chi-square test, Fisher's exact test, and a chi-square test with Yates continuity correction were used to compare qualitative data. Spearman's rank correlation analysis was used to assess relationships between the parameters. Significance was established at p<0.05.
RESULTS
The study group consisted of the newborns of 60 preeclamptic mothers, and 47 newborns from healthy mothers made up the control group. The demographic characteristics of the participants are shown in Table 1 . There was no significant difference in the demographic characteristics between groups (p>0.05; Table 1 ).
The mean serum concentration of vitamin D in the newborns of preeclamptic mothers was 12.62±5.43 ng/mL, while it was 12.85±5.56 ng/mL in the control group. The vitamin D vitamin level was <20 ng/mL in 89.5% of the infants of preeclamptic mothers, and 88.9% of the control group also had a value <20 ng/mL. Tables 2 and 3 illustrate a comparison of the vitamin D, calcium, phosphorus, and magnesium levels of the groups.
There was no statistically significant difference between the 2 groups in terms of vitamin D, calcium, or phosphorus level (p>0.05).
There was a statistically significant difference in the magnesium level (p<0.01). In the study group, the magnesium level was significantly higher than that of the control group. There was a statistically significant correlation between preeclampsia in mothers and the magnesium value in the infant (r=0.355; p=0.012).
DISCUSSION
Contrary to some publications that have reported a lower vitamin D level in the newborns of preeclamptic mothers compared with normotensive mothers, we found no significant difference in the cord blood vitamin D level of preeclamptic and normotensive mothers. The level of vitamin D deficiency and insufficiency was comparable in the 2 groups, and severe deficiency was observed in several cases. The postnatal 24 th hour calcium and phosphorus level of the newborns of preeclamptic mothers were similar. There was no significant difference in the development of hypocalcemia at a level requiring calcium replacement.
It has been reported in the literature that vitamin D may be an independent risk factor in the pathogenesis of preeclampsia. Many studies have been performed related to a hypothesis suggesting a relationship between vitamin D and preeclampsia. In a study examining a relationship between vitamin D deficiency and preeclampsia performed with 32 mothers with an established diagnosis of preeclampsia, it was demonstrated that every 1 standard deviation increase in vitamin D level during the 24 th to 26 th gestational weeks may lead to a 30% reduction in the risk of developing preeclampsia. Halhali et al. [21] analyzed the maternal serum and cord blood level of 1.25 OH vitamin D2 and found lower levels in infants born to preeclamptic mothers.
Several studies have supported the finding that vitamin D levels are significantly lower in the infants of preeclamptic mothers and that maternal blood and umbilical cord blood vitamin D values were correlated. [22] [23] [24] In our study, no significant difference was observed between the cord blood vitamin D level of the infants of preeclamptic and normotensive mothers.
Our findings related to analysis of the presence of minerals associated with vitamin D metabolism revealed no significant difference in the calcium or phosphorus level when comparing the neonates of preeclamptic and normotensive mothers; however, the magnesium level was significantly higher in the preeclamptic group.
The results also revealed a statistically significant correlation between the serum magnesium value in preeclamptic mothers and their infants. This is thought to be due to the fact that the mothers in the study group received magnesium treatment due to preeclampsia. These findings are consistent with findings published in the literature. [25, 26] Vitamin D deficiency is a common public health problem in our country. One study conducted in western Turkey found that the mean vitamin D value in pregnant women and in cord blood was 11.5±5.4 ng/mL and 11.5±6.8 ng/ mL, respectively. [16] The analysis and comparison of cord blood samples in the present study yielded a similar finding (mean: 12.72±5.46 ng/mL). The prevalence of severe deficiencies in our study groups may have prevented the emergence of a difference between the 2 groups. Further studies with a larger number of cases may provide additional meaningful results. The prospective design of our study, the selection of newborns of similar gestational age and weight for the control and the study groups, and the relatively large number of patients enrolled in comparison with some previous studies constitute the strengths of our study.
In conclusion, our study did not indicate any significant difference in the vitamin D level measured in the newborns of preeclamptic and normotensive mothers.
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